Company Analysis

Prestige Consumer Healthcare Inc. (PBH)

NYSE: PBH · Pharmaceutical Preparations · Tarrytown, NY · filing with the SEC since 2004
Grade6.3
◀ Past 7.0● Present 7.0▶ Future 4.7

Filings

181 filings since 2017 beside 324 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-Q Quarterly report for the quarter ending Dec 31, 2026Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by Feb 9, 2027
10-K Annual report for the fiscal year ending Mar 31, 2027Large accelerated filers have 60 days after the fiscal year ends. by May 30, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Jun 29, 2026.

Filings a yearinsider forms included
5445494651735054
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest Aug 14, 2026.
Insider forms 324

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026 10-Q Quarterly report Sep 30, 2026
Nov 5, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Aug 14, 2026 8-K item 5.02 Officer or director change · Current report Aug 10, 2026
Aug 6, 2026 10-Q Quarterly report Jun 30, 2026
Aug 6, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Jul 15, 2026 8-K items 1.01, 2.03, 9.01 Major agreement signed; New debt or obligation taken on · Current report
Jul 9, 2026 8-K/A item 9.01 Financial statements and exhibits · Current report, amended Jun 12, 2026
Jul 7, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 6, 2026 8-K items 1.01, 2.03, 7.01, 9.01 Major agreement signed; New debt or obligation taken on; Investor disclosure (Regulation FD) · Current report Jun 30, 2026
Jun 30, 2026 8-K/A item 9.01 Financial statements and exhibits · Current report, amended Jun 12, 2026
Jun 29, 2026 ARS Annual report to shareholders Mar 31, 2026
Jun 29, 2026 DEF 14A Proxy statement
Jun 16, 2026 8-K items 1.01, 2.01, 2.03, 8.01, 9.01 Major agreement signed; Purchase or sale of a business completed; New debt or obligation taken on; Other event · Current report Jun 12, 2026
May 14, 2026 10-K Annual report Mar 31, 2026
May 13, 2026 8-K items 1.01, 2.02, 7.01, 9.01 Major agreement signed; Results released; Investor disclosure (Regulation FD) · Current report
Apr 30, 2026 SCHEDULE 13G Large holder notice
Apr 29, 2026 SCHEDULE 13G Large holder notice
Mar 27, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 20, 2026 8-K items 1.01, 7.01, 8.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD); Other event · Current report Mar 19, 2026
Feb 13, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 5, 2026 10-Q Quarterly report Dec 31, 2025
Feb 5, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Nov 14, 2025 SCHEDULE 13G Large holder notice
Nov 6, 2025 10-Q Quarterly report Sep 30, 2025
Nov 6, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Aug 13, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 7, 2025 10-Q Quarterly report Jun 30, 2025
Aug 7, 2025 8-K items 1.01, 2.02, 7.01, 9.01 Major agreement signed; Results released; Investor disclosure (Regulation FD) · Current report
Jun 27, 2025 ARS Annual report to shareholders Mar 31, 2025
Jun 27, 2025 DEF 14A Proxy statement Aug 5, 2025
May 9, 2025 10-K Annual report Mar 31, 2025
May 8, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Apr 30, 2025 SCHEDULE 13G/A Large holder update, amended
Feb 7, 2025 SCHEDULE 13G/A Large holder update, amended
Feb 6, 2025 10-Q Quarterly report Dec 31, 2024
Feb 6, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Jan 23, 2025 SCHEDULE 13G/A Large holder update, amended
Jan 6, 2025 8-K items 5.02, 9.01 Officer or director change · Current report
Nov 8, 2024 SC 13G/A Large holder update, amended
Nov 7, 2024 10-Q Quarterly report Sep 30, 2024
40 of 181 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton PBH · research, not advice